 |
|
 |
Advisory Committee on Immunization Practices |
|
| FROM THE CENTERS FOR DISEASE CONTROL AND PREVENTION |
|
ACIP Recommendations: Adolescents |
|
|
| |
|
|
Recommendations - Adolescents |
|
|
|
Prevention and Control of
Meningococcal Disease: Recommendations of the Advisory
Committee on Immunization Practices (ACIP)
Source: MMWR, March 22,
2013; 62(RR02):1-22 |
|
|
HTML | PDF |
ACIP Provisional
Recommendations Prevention of Measles, Rubella, Congenital
Rubella Syndrome (CRS), and Mumps
Source: Centers for Disease Control and Prevention, December
6, 2012 |
|
|
HTML | PDF |
Prevention and Control of Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP)United States, 201213
Influenza Season
Source: MMWR, August 18, 2012;61(32);613-8 |
|
|
HTML | PDF |
Recommendations on the Use of Quadrivalent Human Papillomavirus Vaccine in Males — Advisory Committee on Immunization Practices (ACIP), 2011
Source: MMWR, December 23, 2011; 60(50):1705-8 |
|
| HTML | PDF |
| |
Prevention and Control
of Influenza with Vaccines: Recommendations of the Advisory
Committee on Immunization Practices (ACIP), 2011
Source: MMWR, August 26, 2011; 60(33):1128-1132 |
|
|
HTML | PDF |
Licensure of a Meningococcal
Conjugate Vaccine for Children Aged 2 Through 10 Years and Updated
Booster Dose Guidance for Adolescents and Other Persons at
Increased Risk for Meningococcal Disease Advisory Committee on
Immunization Practices (ACIP), 2011
Source: MMWR, August 5, 2011;
60(30):1018-1019 |
|
|
HTML | PDF |
General Recommendations on
Immunization
Source: MMWR, January 28, 2011; 60(RR02):1-60 |
|
|
HTML | PDF |
|
|
|
Updated Recommendations
for Use of Meningococcal Conjugate Vaccines--Advisory Committee on
Immunization Practices (ACIP), 2010
Source: MMWR, January 28, 2011; 60(03):72-76 |
|
|
HTML | PDF |
| |
Updated Recommendations for Use of
Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis
(Tdap) Vaccine from the Advisory Committee on Immunization
Practices, 2010
Source: MMWR, January 14, 2011;
60(01):13-15 |
|
|
HTML | PDF |
| |
FDA Licensure of Bivalent
Human Papillomavirus Vaccine (HPV2, Cervarix) for Use in Females and
Updated HPV Vaccination Recommendations from the Advisory Committee on
Immunization Practices (ACIP)
Source: MMWR, May 28, 2010;
59(20):626-629 |
|
| HTML | PDF |
| |
FDA Licensure of
Quadrivalent Human Papillomavirus Vaccine (HPV4, Gardasil) for Use in
Males and Guidance from the Advisory Committee on Immunization
Practices (ACIP) Weekly
Source: MMWR, May 28, 2010;
59(20):630-632 |
|
| HTML | PDF |
| |
| Licensure of a Meningococcal Conjugate
Vaccine (Menveo) and Guidance for Use--Advisory Committee on
Immunization Practices (ACIP), 2010 |
|
| HTML | PDF |
| |
Use of Influenza A (H1N1)
2009 Monovalent Vaccine
Source: MMWR, August 28, 2009;
58(RR10):1-8 |
|
| HTML | PDF |
|
Revised Recommendations
of the ACIP to Vaccinate All Persons Aged 11--18 Years with Meningococcal
Conjugate Vaccine
Source: MMWR, August 10, 2007; 56(31):794-795 |
|
| HTML | PDF |
|
Quadrivalent
Human Papillomavirus Vaccine
Source: MMWR, March 23, 2007; 56(RR02):1-24 |
|
| HTML | PDF |
|
Use of Tetanus Toxoid,
Reduced Diphtheria Toxoid and Acellular Pertussis Vaccines Among
Adolescents
Please note: If you are using the HTML version of this document, be
sure to access all the HTML links to get the complete content of the document,
which includes important appendices.
Source:
MMWR, March 24, 2006, Vol. 55(RR03):1-49 |
|
| HTML
pt.1 | HTML
pt.2 | HTML
pt.3 | HTML
pt.4 | HTML
pt.5 | HTML
pt.6 | HTML
pt.7 | PDF
(entire issue) |
|
| This
page was reviewed on
March 22, 2013 |
|
 |
|
|
|
|
|
Immunization Action Coalition • 1573 Selby Ave • St. Paul, MN 55104 |
|
tel 651-647-9009 • fax 651-647-9131 |
|
|
| |
|
|
|
This website is supported in part by a cooperative agreement from the National Center for Immunization and Respiratory Diseases (Grant No. 5U38IP000290) at the Centers for Disease Control and Prevention (CDC) in Atlanta, GA. The website content is the sole responsibility of IAC and does not necessarily represent the official views of CDC. |
|
|
| |
| |
|
|
|